View this email in your browser

April 26, 2021

Biden Finally Agrees that Pandemics are Global  

Help to India on the way. Plus: movement on health care

 

A coronavirus patient in hospital in Mumbai, India. (Rafiq Maqbool/AP
Photo)

The Chief

**** Over one million Indians have contracted coronavirus in the
past three days. Eighty-two hundred and three have died. Those are just
the official cases and almost certainly an undercount; the crematoria
are working so consistently in some cities that the furnaces are melting
.
The official numbers, given population patterns, are just now peaking
above

where the U.S. is at today. However, it's likely cases are
concentrated in the urban centers, it's likelier that this represents
a fraction of those afflicted, and the health system available to all
Indians is in worse shape than ours.

The outbreak comes on the heels of a mass gathering of hundreds of
thousands for Maha Kumbh, a Hindu religious festival, and other large
events. However India got there and however Prime Narendra Modi might be
responsible
,
in a pandemic and a connected world what happens across continents will
likely wind up on our shores, in mutations and variants that just might
not be covered by the current suite of vaccines. So it's an imperative
to vaccinate the entire world, and we won't be safe from crisis until
that happens.

Yet the United States had put an export ban on raw materials

needed to create some of the vaccines. The country is sitting on 30
million AstraZeneca doses

(although they were made at that extremely troubled Baltimore factory)
that it's unlikely to use. And India's health system is in desperate
need of basic supplies, like oxygen
.

**Read all of our First 100 reports here**

Click to Support The American Prospect

**** The first time the State Department was asked about this, on
Friday, its spokesperson first said it was a question for the U.S. trade
representative (not really), and then when pressed noted that the
"United States first and foremost is engaged in an ambitious and
effective and, so far, successful effort to vaccinate the American
people." So India, you get nothing until we get ours. He closed by
flipping the script and saying it was in the interest of the world to
see Americans get vaccinated. Then isn't the converse true? And if you
can help India get vaccinated without affecting the U.S. program at all,
wouldn't you do it?

It took all of 48 hours for the White House to recognize how bad this
looked. In discussions between the two countries' national security
advisors Sunday, the U.S. committed to sending "specific raw material
urgently required for Indian manufacture of the Covishield vaccine" to
India. (Covishield is the brand name for AstraZeneca's vaccine,
incidentally.) We're also sending therapeutic drugs, testing kits,
ventilators, and PPE; are "pursuing options" for oxygen supplies;
and helping to fund India vaccine manufacturer to "produce at least 1
billion doses... by the end of 2022."

Support Independent, Fact-Checked Journalism

OK, this is about a bare minimum start, even if you cast aside the
pledges coming in too late
.
The end of 2022 is a long way off and a billion doses (you need two for
Covishield) won't cover half the Indian population. Covishield, again,
is the same as AstraZeneca, and yet those fully formed AstraZeneca doses
aren't being shipped out.

Longer term, and if we're talking about the end of 2022 we're
talking longer term, the U.S. still hasn't joined the world in
recommending the elimination of intellectual property protections on
COVID-related therapies and vaccines, known as a TRIPS waiver
. (TRIPS
stands for Trade-Related Aspects of Intellectual Property, which is
actually TRAIP, so I don't know.) Pharma lobbyists (in association
with lover of IP barriers Bill Gates
)
have been making the same point for 10 months, that waiving IP
wouldn't do anything of value because it takes too long to add
manufacturing capacity. First of, if waiving TRIPS won't do anything,
why has an army of lobbyists been deployed to prevent it? Second,
BioNTech, Pfizer's partner, bought a German plant in Marburg that had
no experience with mRNA and brought it to production
in six
months. The "it'll take too long" talking point has wasted lives,
and the best day to end that is today.

Help Keep the Prospect Paywall-Free

The wacky new talking point, unleashed in the Financial Times
, is
that waiving IP might allow CHINA AND RUSSIA to... cure cancer.
Seriously, that's the claim. I'm supposed to be so nationalist that
I don't want to lose a curing-cancer race to a foreign country. If
this is all they've got, there really is no justification other than
profit.

Here's the part of this that's worth monitoring: U.S. trade
representative Katherine Tai has put the TRIPS waiver under review,
meeting with stakeholders and making statements leaning in the direction
of the waiver at a WTO meeting. This led to "one vaccine maker to
complain to White House officials" about Tai.

There's something hilarious in pharma CEOs calling mom and dad at the
White House because Katherine Tai was being mean and threatening their
cash cow. But looking closer, it seems that the pharma lobby believes
that the White House runs trade policy rather than the U.S. trade
representative. This is something we've been concerned about
. USTR recently nominated a top
deputy

to run the critical China portfolio who has no experience with trade or
China. It felt like a demotion for USTR; note that the call to India was
with national security advisor Jake Sullivan, not Tai. A White House
bigfooting of a fairly progressive trade rep has implications that go
well beyond vaccine IP; this bears watching.

We Depend on Your Donations

And Don't Forget Health Care

On Friday it appeared that Biden would announce his American Families
Plan with no provision on a critical hardship for American families,
health care
.
This spurred some rapid response, both from the "expand Medicare"
movement

led by Sen. Bernie Sanders (I-VT) and close to 20 other Senate
Democrats, and the "expand the Affordable Care Act" movement

led by a couple dozen freshman and sophomore House Democrats.

Sure enough, by the weekend, it was floated that the plan now includes
$200 billion

to extend insurance exchange subsidies, so nobody has to pay more than
8.5 percent in income for an insurance premium. This was passed in the
American Rescue Plan but only for two years. A measure to lower the
price of prescription drugs, however, appears to still be on the
sidelines.

Once again the White House proves itself malleable on policy, though it
has taken a side in the "improve private health care vs. improve
public health care" debate. But so much of this remains theoretical.
Emperor-king Joe Manchin wants to limit the bill

to "conventional infrastructure" and involve Republicans, and if he
wants that, we're headed for a final package that's about
one-seventh the size of the Jobs and Families plans. Making plans is
nice, but it might just be pushing paper.

What Day of Biden's Presidency Is It?

Day 97. Yes, this is the last week for First 100.

We Can't Do This Without You

Today I Learned

* The Shuttered Venue Operator Grants application portal is supposed to
reopen today;
initially it was Saturday
,
so we're already one delay in. (SBA, Twitter)

* Meanwhile, rental assistance

is another minefield that isn't actually getting out to beneficiaries.
(New York Times)

* Biden approval holding steady

at a couple points above his share of the two-party vote in 2020. There
just aren't many persuadables anymore. (Axios)

* "The Biden administration changed its story on refugees 6 times in 3
weeks
."
(Washington Post)

* Shutdown process beginning in Afghanistan
.
(Associated Press)

* Outdoor mask guidance is going to be relaxed
;
if you're distanced and outdoors, you don't need it. (CNBC)

* The women of Bears Ears national monument pleading for restoration

suggests that the administration's action on Day One isn't a done
deal. (New York Times)

* Biden acknowledges the Armenian genocide
.
(Yahoo News)

**Click the social links below to share this newsletter**

 

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

YOUR TAX DEDUCTIBLE DONATION SUPPORTS INDEPENDENT JOURNALISM

Copyright (C) 2021 The American Prospect. All rights reserved.
_________________

Sent to [email protected]

Unsubscribe:
[link removed]

The American Prospect, Inc., 1225 I Street NW, Suite 600, Washington, DC xxxxxx, United States